Clinical trial
Postoperative Conventional Versus Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy in Cervical Cancer: A Prospective Multicenter Randomized Phase III Trial (POHIM_P3 Trial)
NCT06509724 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postoperative Conventional Versus Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy in Cervical Cancer: A Prospective Multicenter Randomized Phase III Trial (POHIM_P3 Trial)
- Lead sponsor
- Samsung Medical Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 19, 2024
- Completion date
- December 31, 2032
- Enrollment
- 248 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.